unilife corp-cdi (UNISZ) Key Developments
Unilife Corporation - Special Call
Jul 29 15
To update shareholders on its business activities and introduce the Imperium™ platform of instant insulin patch pumps
Unilife Corporation Announces Introduction of Imperium™ Platform of Instant Patch Pumps for Insulin
Jul 29 15
Unilife Corporation announced the introduction of the Imperium™ platform of instant patch pumps for insulin. Imperium is a prefilled, disposable, multi-day wearable insulin pump that does not require filling or assembly by the patient. Because it is prefilled and pre-assembled like an insulin pen, only three intuitive steps are required to commence continuous subcutaneous insulin infusion, with on-demand bolus delivery available to the user via the simple push of a button. Imperium can include wireless connectivity systems, such as Bluetooth LE, to integrate with smartphone apps for patient reminders and status updates. With data connectivity available, healthcare providers could also have access to real-time or historic data to tailor the insulin therapy for each patient to achieve and maintain glycemic control. Imperium is designed for supply to a select insulin partner or partners ready for filling and packaging using standard pharmaceutical processes, materials and equipment. Insulin partners can then sell the prefilled, fully-assembled device through existing commercial channels, with no sales, marketing, commercial development, reimbursement, and clinical support costs to Unilife. As a prefilled, high-precision device with a delivery resolution of 0.5µL, Imperium is suitable for use with high concentration insulins up to U-500.
Unilife Corporation Mulls Acquisitions
Jul 29 15
Unilife Corporation (ASX:UNS) is seeking acquisitions. Unilife Corporation has signed an equity purchase agreement for up to AUD 45 million with Lincoln Park Capital Fund, LLC which provides the company with AUD 5 million in initial net proceeds and the option to generate, at its sole control and discretion, up to AUD 40 million in additional net proceeds over 24 months. Unilife Corporation said, “The Company intends to use the net proceeds received from the financing with Lincoln Park Capital Fund, LLC and the at-the-market facility for investments in its plant, equipment, systems and personnel to further develop its manufacturing and operational capabilities to satisfy current and future customer orders and general corporate purposes, including working capital, acquisitions and other business opportunities.”
Unilife Corporation Amends Debt Financing Agreement with Orbimed
Jul 2 15
Unilife Corporation said that it has amended its debt agreement with OrbiMed as of 30 June 2015. Under the amendment, OrbiMed has removed a covenant that required Unilife to generate at least USD 20 million in cash receipts from customers during the six months ended 30 June 2015. There were no other adjustments to any of the terms of the debt agreement as part of this amendment.
Unilife Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 03:00 PM
May 28 15
Unilife Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 03:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Alan D. Shortall, Chairman, Chief Executive Officer, Member of Strategic Partnerships Committee and Chief Executive Officer of UMSL.